John Anderson: Conversations
Erasing Sex & Reality: The Tickle v Giggle Case | Sall Grover
11 Aug 2025
In this conversation, John chats with Giggle for Girls founder Sall Grover about her recent high-stakes Federal Court appeal concerning the right to operate a women-only social networking app. Grover warns that without clear sex-based protections, women’s rights to privacy, safety, and dignity in public and private spaces risk being dismantled.The conversation explains why the ruling will not merely have ramifications for women's rights, but the fundamental freedoms of belief, association, and speech — principles essential to a free and democratic society. Grover also highlights the political reluctance to confront the issue, and the double standards of many Australian media outlets that have remained conspicuously silent in coverage of the case.Sall Grover is the founder and CEO of Giggle, a female-only social networking app launched in 2020 to provide a secure platform for women to connect, collaborate, and support one another. Giggle has been at the centre of the recent landmark Federal Court case Tickle v Giggle, which tested the application of Australia’s Sex Discrimination Act to women-only spaces.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare